Syngenta has received the green light from the EPA for the registration of its Vibrance Trio seed treatment. The premix of three fungicide active ingredients – mefenoxam, fludioxonil, and sedaxane – is recommended for soybean growers whose main early-season concerns are strong stands and disease protection.
“The higher rate of mefenoxam in Vibrance Trio offers the highest level of Phytophthora and Pythium protection available,” said Steve Gomme, Seedcare product lead at Syngenta. “This helps give growers confidence when they desire early planting in unpredictable conditions, establishing stronger soybean stands, and reducing the risk of replants.”
Regardless of planting conditions, Vibrance Trio helps provide protection from these early-season soybean diseases:
- Seedborne Phomopsis
- Seedborne Sclerotinia
In addition to its activity on Rhizoctonia, the sedaxane in Vibrance Trio offers RootingPower that creates healthier, more robust roots to help produce better yields.
“Much like tree branches, roots grow larger by developing root tips that fork and grow. The more forks that are present, the more root surface area that exists,” said Gomme. “It’s this root surface area that determines the amount of moisture and nutrients that can be taken up into developing soybean seedlings, as well as the size and density of beans ultimately produced by mature plants. In other words, robust root systems play a big role in driving yield potential.”
Stronger roots also enable soybeans to withstand environmental stress. In trials conducted over three years and across 31 different field environments, the early-season disease protection of Vibrance Trio resulted in a higher stand count 87 percent of the time, when compared to a check treatment. Additionally, in trials conducted over two years, Vibrance Trio increased yield by an average of 2.2 bushels per acre, compared to the industry standard in heavy disease environments.